Breeding Specialized Mosquitoes to Combat Dengue: A Shift from Adversaries to Allies

34

For years, the common practice for dengue prevention in Honduras has been public education campaigns designed to create an aversion to mosquitoes and their bites. However, the tide is turning, thanks to a new approach that contradicts conventional wisdom.

Last month, residents of Tegucigalpa looked on as Hector Enriquez, a 52-year-old mason, released a swarm of unique mosquitoes into the air. Enriquez was part of an initiative to mitigate the spread of dengue by releasing millions of genetically modified mosquitoes throughout the capital city.

These particular mosquitoes, unleashed in an area known for high dengue infection rates, were scientifically engineered to carry Wolbachia bacteria, which inhibit the disease’s transmission. When these modified mosquitoes reproduce, they pass on the Wolbachia bacteria to their progeny, thereby lowering the risk of future outbreaks.

The innovative methodology is a product of the World Mosquito Program, a nonprofit organization. Currently under trial in various countries, this strategy is drawing the attention of the World Health Organization (WHO), which is considering advocating for its global application.

In Honduras, where dengue annually affects approximately 10,000 individuals, Médecins Sans Frontières (Doctors Without Borders) is collaborating with the World Mosquito Program to release nearly 9 million Wolbachia-infected mosquitoes over the upcoming six months.

Conventional Prevention Methods Fall Short

Advancements in combatting mosquito-borne diseases like malaria have been significant. However, dengue remains a stubborn exception, with infection rates continually on the rise. Approximately 400 million people worldwide are infected annually, mostly in around 130 countries. Although the mortality rate from dengue is relatively low—about 40,000 deaths per year—the disease poses a severe burden on healthcare systems and can cause debilitating illness.

Preventive measures, such as insecticides and vaccines, have proven to be less effective against dengue. The Aedes aegypti mosquitoes, the primary carriers of the disease, exhibit resistance to insecticides and are active during daylight, making bed nets less useful. Moreover, the existence of four different forms of the dengue virus complicates vaccination efforts.

The Wolbachia Breakthrough

This revolutionary approach has been years in the making. Initially, Wolbachia was considered as a means to reduce mosquito populations. However, researchers made an unanticipated discovery: mosquitoes carrying Wolbachia bacteria were incapable of transmitting dengue and other related diseases like yellow fever and Zika.

The strategy involves replacing local mosquito populations with Wolbachia-carrying variants. Initial trials across 14 countries, affecting 11 million people, have shown promising results. For instance, a large-scale field trial in Indonesia indicated a 76% reduction in dengue cases post-release of the Wolbachia-infected mosquitoes.

Nevertheless, questions remain, including the strategy’s scalability and its long-term effectiveness, as well as the mechanisms through which Wolbachia inhibits viral transmission.

Industrial-Scale Breeding in Colombia

The World Mosquito Program operates a breeding facility in Medellín, Colombia, capable of producing 30 million Wolbachia-infected mosquitoes each week. Here, dried mosquito eggs from diverse global regions are imported and hatched to maintain genetic diversity and insecticide resistance. The eggs are then exposed to the “mother colony,” a Wolbachia-infected lineage, to ensure the bacteria’s propagation.

Community Involvement in Honduras

In Tegucigalpa, Doctors Without Borders teams have been engaging communities, even liaising with influential local figures like gang leaders, to educate the public and solicit cooperation. While there have been questions about the environmental and health impacts of the Wolbachia-infected mosquitoes, outreach workers have been able to assuage these concerns.

As global dengue cases rise and traditional preventive measures fail to provide a solution, the Wolbachia strategy offers a new avenue for combating this persistent and debilitating disease. While it may not be a “silver bullet,” the early indicators are promising, and it stands as an innovative departure from the status quo in dengue prevention.

Frequently Asked Questions (FAQs) about Genetically Modified Mosquitoes in Dengue Control

More about Genetically Modified Mosquitoes in Dengue Control

• Genetically Modified Mosquitoes: An Overview
• Self-limiting Genes and Their Applications
• Environmental Impacts of Genetically Modified Organisms
• Regulatory Framework for GMOs in Public Health
• Effectiveness of GM Mosquitoes in Controlling Dengue Fever
• Ethical Concerns in Genetic Modification for Public Health
• Alternative Methods for Controlling Dengue Fever